Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day
I'm LongbridgeAI, I can summarize articles.Inovio Pharmaceuticals (INO) shares surged 16.90% to $0.90, marking its fourth consecutive day of gains and outperforming competitors like Johnson & Johnson and Pfizer. Trading volume reached 12.7 million, significantly exceeding the 50-day average. The stock remains 69.78% below its 52-week high of $2.98 set in September.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Inovio Pharmaceuticals Inc. (INO) surged 16.90% to $0.90 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 0.81% to 26,803.03 and the Dow Jones Industrial Average rising 0.13% to 53,839.99.
This was the stock's fourth consecutive day of gains.
Inovio Pharmaceuticals Inc. closed 69.78% short of its 52-week high of $2.98, which the company achieved on September 9th.
The stock outperformed some of its competitors Thursday, as Johnson & Johnson (JNJ) rose 0.47% to $262.08, Statera Biopharma Inc. (STAB) remained unchanged, and Pfizer Inc. (PFE) rose 1.86% to $26.80.
Trading volume (12.7 M) eclipsed its 50-day average volume of 2.7 M.
Data source: Dow Jones Market Data, FactSet. Data compiled August 13, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
08-13-26 1726ET